Celanese Corp. 10-Q Summary: Quarter Ended September 30, 2006
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Celanese Corporation, a global hybrid chemical company, for the period ended September 30, 2006. The company operates through four primary segments: Chemical Products, Technical Polymers Ticona, Acetate Products, and Performance Products. The report includes unaudited consolidated financial statements and management discussion regarding the company's financial condition and results of operations.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2006 | Nine Months Ended Sep 30, 2006 |
|---|---|---|
| Net Sales | $1,685 million | $5,000 million |
| Gross Profit | $367 million (21.8% margin) | $1,084 million (21.7% margin) |
| Operating Profit | $200 million (11.9% margin) | $562 million (11.2% margin) |
| Net Earnings | $109 million | $329 million |
| Diluted EPS (Continuing Ops) | $0.63 | $1.91 |
| Cash and Cash Equivalents | $513 million (as of Sep 30, 2006) | N/A |
| Total Debt | $3,449 million (as of Sep 30, 2006) | N/A |
| Operating Cash Flow (9mo) | N/A | $415 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.4% for the quarter and 11.3% for the nine-month period compared to 2005. Growth was driven by a 4% price increase and 4% volume increase in the quarter, with significant contributions from the Acetex acquisition ($413 million in sales for the nine months).
- Profitability: Operating profit surged 110.5% for the quarter and 38.4% for the nine months. This improvement was driven by higher pricing, productivity gains, and a significant reduction in "Other (charges) gains, net" compared to 2005, which included one-time charges for asset impairments and restructuring.
- Segment Performance:
- Chemical Products: Sales up 10% (quarter) and 11% (nine months); Operating profit up 68% (quarter) and 9% (nine months).
- Ticona: Sales up 8% (quarter); Operating profit up 106% (quarter) due to volume growth and the exit of the COC business.
- Acetate Products: Operating profit increased 475% (quarter) and 213% (nine months) due to higher pricing and restructuring savings.
- Performance Products: Sales declined 11% in the quarter due to lower volumes and pricing, though nine-month sales were relatively flat.
- Interest Expense: Decreased 31% for the nine-month period compared to 2005, primarily due to the absence of $74 million in early redemption premiums and $28 million in accelerated amortization of financing costs recorded in the prior year.
Guidance, Outlook, Risks, and Unusual Items
- Acquisitions and Divestitures: The company signed a definitive agreement in August 2006 to acquire the cellulose acetate business of Acetate Products Limited (APL), expected to close in Q4 2006. The company discontinued its Pentaerythritol (PE) operations in Q3 2006.
- Legal Proceedings:
- Squeeze-Out Litigation: Minority shareholders of Celanese AG (CAG) filed 17 actions to set aside the Squeeze-Out resolution. The court granted a petition to initiate a release proceeding in October 2006, but the outcome remains uncertain.
- Antitrust: The company is a defendant in polyester staple antitrust litigation and sorbates antitrust actions. Accruals for sorbates totaled $141 million as of September 30, 2006.
- Plumbing Cases: Accruals for defective plumbing actions were $66 million, with $23 million in receivables from insurance carriers.
- Export Control Violations: The company voluntarily disclosed violations of U.S. export control laws involving sales to Cuba, Iran, and Syria. The company has terminated an employee and liquidated its Turkish subsidiary. Potential fines and sanctions cannot be estimated at this time.
- Capital Structure: The company paid $19 million in common dividends and $8 million in preferred dividends during the nine months. A $100 million voluntary prepayment was made on the Senior Term Loan facility in July 2006.
- Accounting Changes: Adoption of SFAS No. 123(R) for stock-based compensation reduced net earnings by $3 million (quarter) and $9 million (nine months) compared to prior accounting methods.
Investor Verification Checklist
- Verify the status and potential financial impact of the pending Squeeze-Out litigation regarding Celanese AG minority shareholders.
- Monitor the resolution of the voluntary disclosure regarding U.S. export control violations and potential associated fines.
- Assess the integration and financial contribution of the Acetex acquisition and the pending APL acquisition.
- Review the company's ability to maintain pricing power in the Chemical Products and Ticona segments amidst rising raw material costs.
- Confirm the company's compliance with debt covenants given the total debt load of approximately $3.45 billion.